Efficacy of endolymphatic duct blockage in treating Ménière's disease

Tao Yang1,2,3, Zhiwen Zhang4,5, Qin Wang4,5

  • 1Department of Otolaryngology-Head and Neck Surgery, Second Xiangya Hospital, Central South University, Changsha 410011. yt7065@csu.edu.cn.

Abstract

Insights

Endolymphatic duct blockage surgery for Ménière

Area of Science:

  • Otolaryngology
  • Neurosurgery
  • Inner ear disorders

Background:

  • Ménière's disease (MD) is an idiopathic inner ear condition causing vertigo, hearing loss, tinnitus, and ear fullness.
  • Endolymphatic sac (ES) surgery is a treatment option for MD unresponsive to medication.
  • Endolymphatic duct blockage (EDB) is an emerging surgical procedure for MD.

Purpose of the Study:

  • To investigate dynamic changes in endolymphatic hydrops (EH) after EDB surgery.
  • To assess long-term surgical outcomes in MD patients undergoing EDB.
  • To evaluate the impact of endolymphatic sac morphology on EDB efficacy.

Main Methods:

  • Retrospective analysis of 33 refractory MD patients who underwent EDB.
  • Patients classified into normal-type (n=14) and atrophic-type (n=19) ES groups.
  • Comparison of vertigo, hearing, vestibular function, and MRI findings pre- and post-surgery.

Main Results:

  • The normal-type ES group showed significantly better vertigo control, cochlear/vestibular function, and lower endolymph volume compared to the atrophic-type group (P<0.05).
  • Reversal of EH occurred in 7 normal-type patients, but not in the atrophic-type group.
  • Surgical outcomes for EDB varied based on ES morphology.

Conclusions:

  • EDB treatment response differs between normal and atrophic endolymphatic sac types in MD patients.
  • ES morphology may indicate distinct underlying disease mechanisms in Ménière's disease.
  • Further research is needed to understand the implications of ES pathology for EDB treatment effectiveness.